Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity

Cancer Commun (Lond). 2023 Oct;43(10):1178-1182. doi: 10.1002/cac2.12474. Epub 2023 Jul 31.
No abstract available

Publication types

  • Letter